410 related articles for article (PubMed ID: 28276704)
1. Cell-impedance-based label-free technology for the identification of new drugs.
Lundstrom K
Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
[TBL] [Abstract][Full Text] [Related]
2. Using label-free screening technology to improve efficiency in drug discovery.
Halai R; Cooper MA
Expert Opin Drug Discov; 2012 Feb; 7(2):123-31. PubMed ID: 22468914
[TBL] [Abstract][Full Text] [Related]
3. Label-free screening assays: a strategy for finding better drug candidates.
Lunn CA
Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
[TBL] [Abstract][Full Text] [Related]
4. Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
Martin J
Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.13. PubMed ID: 22294376
[TBL] [Abstract][Full Text] [Related]
5. Towards the miniaturization of GPCR-based live-cell screening assays.
Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of biosensor-based epitope binning and mapping in antibody-based drug discovery.
Ditto NT; Brooks BD
Expert Opin Drug Discov; 2016 Oct; 11(10):925-37. PubMed ID: 27600831
[TBL] [Abstract][Full Text] [Related]
7. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
Heeres JT; Hergenrother PJ
Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
[TBL] [Abstract][Full Text] [Related]
9. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.
Ramasamy S; Bennet D; Kim S
Int J Nanomedicine; 2014; 9():5789-809. PubMed ID: 25525360
[TBL] [Abstract][Full Text] [Related]
10. Back to basics: label-free technologies for small molecule screening.
Shiau AK; Massari ME; Ozbal CC
Comb Chem High Throughput Screen; 2008 Mar; 11(3):231-7. PubMed ID: 18336215
[TBL] [Abstract][Full Text] [Related]
11. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
12. Mining the Potential of Label-Free Biosensors for In Vitro Antipsychotic Drug Screening.
Kilic T; Soler M; Fahimi-Kashani N; Altug H; Carrara S
Biosensors (Basel); 2018 Jan; 8(1):. PubMed ID: 29315269
[TBL] [Abstract][Full Text] [Related]
13. Label-free drug screening assay multiplexed with an orthogonal time-resolved fluorescence labeled assay.
Kiss L; Cselenyák A; Visegrády A
Anal Biochem; 2019 Feb; 566():126-132. PubMed ID: 30452893
[TBL] [Abstract][Full Text] [Related]
14. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M
J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830
[TBL] [Abstract][Full Text] [Related]
16. Mining the potential of label-free biosensors for seven-transmembrane receptor drug discovery.
Rocheville M; Martin J; Jerman J; Kostenis E
Prog Mol Biol Transl Sci; 2013; 115():123-42. PubMed ID: 23415093
[TBL] [Abstract][Full Text] [Related]
17. Label-Free Dynamic Mass Redistribution and Bio-Impedance Methods for Drug Discovery.
Grundmann M
Curr Protoc Pharmacol; 2017 Jun; 77():9.24.1-9.24.21. PubMed ID: 28640952
[TBL] [Abstract][Full Text] [Related]
18. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool.
Doijen J; Van Loy T; Landuyt B; Luyten W; Schols D; Schoofs L
Biosens Bioelectron; 2019 Jul; 137():33-44. PubMed ID: 31077988
[TBL] [Abstract][Full Text] [Related]
19. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
20. Label-free technologies and pharmacology.
Fang Y
Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
